309 related articles for article (PubMed ID: 24563484)
1. A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16.
Pan TC; Zhang RZ; Arita M; Bogdanovich S; Adams SM; Gara SK; Wagener R; Khurana TS; Birk DE; Chu ML
J Biol Chem; 2014 Apr; 289(15):10293-10307. PubMed ID: 24563484
[TBL] [Abstract][Full Text] [Related]
2. New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype.
Pan TC; Zhang RZ; Sudano DG; Marie SK; Bönnemann CG; Chu ML
Am J Hum Genet; 2003 Aug; 73(2):355-69. PubMed ID: 12840783
[TBL] [Abstract][Full Text] [Related]
3. COL6A3 protein deficiency in mice leads to muscle and tendon defects similar to human collagen VI congenital muscular dystrophy.
Pan TC; Zhang RZ; Markova D; Arita M; Zhang Y; Bogdanovich S; Khurana TS; Bönnemann CG; Birk DE; Chu ML
J Biol Chem; 2013 May; 288(20):14320-14331. PubMed ID: 23564457
[TBL] [Abstract][Full Text] [Related]
4. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy.
Baker NL; Mörgelin M; Peat R; Goemans N; North KN; Bateman JF; Lamandé SR
Hum Mol Genet; 2005 Jan; 14(2):279-93. PubMed ID: 15563506
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Molecular Spectrum Associated with COL6A3 c.7447A>G p.(Lys2483Glu) Variant: Elucidating its Role in Collagen VI-related Myopathies.
Villar-Quiles RN; Donkervoort S; de Becdelièvre A; Gartioux C; Jobic V; Foley AR; McCarty RM; Hu Y; Menassa R; Michel L; Gousse G; Lacour A; Petiot P; Streichenberger N; Choumert A; Declerck L; Urtizberea JA; Sole G; Furby A; Cérino M; Krahn M; Campana-Salort E; Ferreiro A; Eymard B; Bönnemann CG; Bharucha-Goebel D; Sumner CJ; Connolly AM; Richard P; Allamand V; Métay C; Stojkovic T
J Neuromuscul Dis; 2021; 8(4):633-645. PubMed ID: 33749658
[TBL] [Abstract][Full Text] [Related]
6. Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance.
Lampe AK; Zou Y; Sudano D; O'Brien KK; Hicks D; Laval SH; Charlton R; Jimenez-Mallebrera C; Zhang RZ; Finkel RS; Tennekoon G; Schreiber G; van der Knaap MS; Marks H; Straub V; Flanigan KM; Chu ML; Muntoni F; Bushby KM; Bönnemann CG
Hum Mutat; 2008 Jun; 29(6):809-22. PubMed ID: 18366090
[TBL] [Abstract][Full Text] [Related]
7. Collagen VI-Related Myopathy Caused by Compound Heterozygous Mutations of COL6A3 in a Consanguineous Kurdish Family.
Mihaylova V; Chablais F; Bremer J; Guggenberger R; Rushing EJ; Bethge T; Spiegel R; Jung HH
J Clin Neuromuscul Dis; 2021 Mar; 22(3):173-179. PubMed ID: 33596003
[TBL] [Abstract][Full Text] [Related]
8. Collagen VI disorders: Insights on form and function in the extracellular matrix and beyond.
Lamandé SR; Bateman JF
Matrix Biol; 2018 Oct; 71-72():348-367. PubMed ID: 29277723
[TBL] [Abstract][Full Text] [Related]
9. Autosomal recessive inheritance of classic Bethlem myopathy.
Foley AR; Hu Y; Zou Y; Columbus A; Shoffner J; Dunn DM; Weiss RB; Bönnemann CG
Neuromuscul Disord; 2009 Dec; 19(12):813-7. PubMed ID: 19884007
[TBL] [Abstract][Full Text] [Related]
10. Aberrant mitochondria in a Bethlem myopathy patient with a homozygous amino acid substitution that destabilizes the collagen VI α2(VI) chain.
Zamurs LK; Idoate MA; Hanssen E; Gomez-Ibañez A; Pastor P; Lamandé SR
J Biol Chem; 2015 Feb; 290(7):4272-81. PubMed ID: 25533456
[TBL] [Abstract][Full Text] [Related]
11. Autosomal recessive Bethlem myopathy: A clinical, genetic and functional study.
Caria F; Cescon M; Gualandi F; Pichiecchio A; Rossi R; Rimessi P; Cotti Piccinelli S; Gallo Cassarino S; Gregorio I; Galvagni A; Ferlini A; Padovani A; Bonaldo P; Filosto M
Neuromuscul Disord; 2019 Sep; 29(9):657-663. PubMed ID: 31471117
[TBL] [Abstract][Full Text] [Related]
12. Collagen type VI myopathies.
Bushby KM; Collins J; Hicks D
Adv Exp Med Biol; 2014; 802():185-99. PubMed ID: 24443028
[TBL] [Abstract][Full Text] [Related]
13. Effects on collagen VI mRNA stability and microfibrillar assembly of three COL6A2 mutations in two families with Ullrich congenital muscular dystrophy.
Zhang RZ; Sabatelli P; Pan TC; Squarzoni S; Mattioli E; Bertini E; Pepe G; Chu ML
J Biol Chem; 2002 Nov; 277(46):43557-64. PubMed ID: 12218063
[TBL] [Abstract][Full Text] [Related]
14. Bethlem myopathy and engineered collagen VI triple helical deletions prevent intracellular multimer assembly and protein secretion.
Lamandé SR; Shields KA; Kornberg AJ; Shield LK; Bateman JF
J Biol Chem; 1999 Jul; 274(31):21817-22. PubMed ID: 10419498
[TBL] [Abstract][Full Text] [Related]
15. [Collagenopathy (Ullrich congenital muscular dystrophy, Bethlem myopathy)].
Higuchi I
Rinsho Shinkeigaku; 2005 Nov; 45(11):935-7. PubMed ID: 16447767
[TBL] [Abstract][Full Text] [Related]
16. Collagen VI Muscle Disorders: Mutation Types, Pathogenic Mechanisms and Approaches to Therapy.
Lamandé SR
Adv Exp Med Biol; 2021; 1348():311-323. PubMed ID: 34807426
[TBL] [Abstract][Full Text] [Related]
17. The collagen VI-related myopathies: muscle meets its matrix.
Bönnemann CG
Nat Rev Neurol; 2011 Jun; 7(7):379-90. PubMed ID: 21691338
[TBL] [Abstract][Full Text] [Related]
18. [Collagen VI-related muscle disorders].
Higuchi I
Brain Nerve; 2011 Nov; 63(11):1169-78. PubMed ID: 22068469
[TBL] [Abstract][Full Text] [Related]
19. Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy.
Demir E; Sabatelli P; Allamand V; Ferreiro A; Moghadaszadeh B; Makrelouf M; Topaloglu H; Echenne B; Merlini L; Guicheney P
Am J Hum Genet; 2002 Jun; 70(6):1446-58. PubMed ID: 11992252
[TBL] [Abstract][Full Text] [Related]
20. Molecular consequences of dominant Bethlem myopathy collagen VI mutations.
Baker NL; Mörgelin M; Pace RA; Peat RA; Adams NE; Gardner RJ; Rowland LP; Miller G; De Jonghe P; Ceulemans B; Hannibal MC; Edwards M; Thompson EM; Jacobson R; Quinlivan RC; Aftimos S; Kornberg AJ; North KN; Bateman JF; Lamandé SR
Ann Neurol; 2007 Oct; 62(4):390-405. PubMed ID: 17886299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
